Growth factors and bone

Growth Factors and Cytokines in Health and Disease

Volumn 3, Issue C, 1997, Pages 127-155

  Delany, Anne M ^a   Canalis, Ernesto ^b  

^a Medical Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000513910     PISSN: 18745687     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5687(97)80005-5     Document Type: Review

References (201)

1. Abraham J.A., Whang J.L., Tumolo A., Mergia A., Friedman J., Gospodarowicz J., and Fiddes J.C. Human basic fibroblast growth factor: Nucleotide sequence and genomic organization. EMBO J. 5 (1986) 2523-2528
2. Adamo M.L., Lanau F., Neuenschwander S., Werner H., LeRoith D., and Roberts Jr. C.T. Distinct promoters in the rat insulin-like growth factor-I (IGF-I) gene are active in CHO cells. Endocrinology 132 (1993) 935-937
3. Andress D.L., and Birnbaum R.S. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem. 267 (1992) 22467-22472
4. Arai T., Parker A., Busby Jr. W., and Clemmons D.R. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. J. Biol. Chem. 269 (1994) 20388-20393
5. Bach L.A., Hsieh S., Sakano K., Fujiwara H., Perdue J.F., and Rechler M.M. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. J. Biol. Chem. 268 (1993) 9246-9254
6. Baird A. Editorial: Fibroblast growth factors: What's in a name?. Endocrinology 132 (1993) 487-488
7. Barnard J.A., Lyons R.M., and Moses H.L. The cell biology of transforming growth factor β Biochim. Biophys. Acta 1032 (1990) 79-87
8. Bassing C.H., Howe D.J., Segarin P.R., Donahoe P.K., and Wang X.-F. A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-β ligands. J. Biol. Chem. 269 (1994) 14861-14864
9. Bautista C.M., Baylink D.J., and Mohan S. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF II in human bone. Biochem. Biophys. Res. Commun. 176 (1991) 756-763
10. Beck L.S., Chen T.L., Mikalauski P., and Ammann A.J. Recombinant human transforming growth factor-beta 1 (rhTGF-β1) enhances healing and strength of granulation skin wounds. Growth Factors 3 (1990) 267-275
11. Betsholtz C., Johnsson A., Heldin C.-H., Westermark B., Lind P., Urdea M.S., Eddy R., Shows T.B., Philpott K., Mellor A.L., Knott T.J., and Scott J. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320 (1986) 695-699
12. Bhandari B., Grandaliano G., and Abboud H.E. Platelet-derived growth factor (PDGF) BB homodimer regulates PDGF A- and PDGF B-chain gene transcription in human mesangial cells. Biochem. J. 297 (1994) 385-388
13. Birnbaum R.S., and Wiren K.M. Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology 135 (1994) 223-230
14. 3 on differentiation of a human osteosarcoma (MG-63). J. Biol. Chem. 267 (1992) 8943-8949
15. Brummel T.J., Twombly V., Marques G., Wrana J.L., Newfeld S.J., Attisano L., Massague J., O'Connor M.B., and Gelbart W.M. Characterization and relationship of dpp receptors encoded by the saxophone and thick veins genes in drosophila. Cell 78 (1994) 251-261
16. Burgess W.H., and Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58 (1989) 575-606
17. Campbell G., and Novak J.F. Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells. J. Cell. Physiol. 149 (1991) 293-300
18. Canalis E. Editorial: Skeletal growth factors and aging. J. Clin. Endocrinol. Metab 78 (1994) 1009-1010
19. Canalis E., and Gabbitas B. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures. J. Bone Miner. Res. 9 (1994) 1999-2005
20. Canalis E., and Gabbitas B. Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures. J. Biol. Chem. 270 (1995) 10771-10776
21. Canalis E., Lorenzo J., Burgess W.H., and Maciag T. Effects of endothelial cell growth factor on bone remodeling in vitro. J. Clin. Invest. 79 (1987) 52-58
22. Canalis E., Centrella M., and McCarthy T. Effects of basic fibroblast growth factor on bone formation in vitro. J. Clin. Invest. 81 (1988) 1572-1577
23. Canalis E., McCarthy T., and Centrella M. Isolation of growth factors from adult bovine bone. Calcif. Tissue Int. 43 (1988) 346-351
24. Canalis E., McCarthy T.L., and Centrella M. Effects of platelet-derived growth factor on bone formation in vitro. J. Cell Physiol. 140 (1989) 530-537
25. Canalis E., Varghese S., McCarthy T.L., and Centrella M. Role of platelet-derived growth factor in bone cell function. Growth Regul. 2 (1992) 151-155
26. Canalis E., Pash J., Gabbitas G., Rydziel S., and Varghese S. Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures. Endocrinology 133 (1993) 33-38
27. Canalis E., Hock J.M., and Raisz L.G. Anabolic and catabolic effects of parathyroid hormone on bone and interactions with growth factors. In: Bilezikian J.P., Levine M.A., and Marcus R. (Eds). The Parathyroids (1994), Raven Press, Ltd., Berlin 65-82
28. Canalis E., Rydziel S., Delany A.M., Varghese S., and Jeffrey J.J. Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136 (1995) 1348-1354
29. Carter B.Z., and Malter J.S. Biology of disease. Regulation of mRNA stability and its relevance to disease. Lab. Invest. 65 (1991) 610-621
30. Celeste A.J., Iannazzi J.A., Taylor R.C., Hewick R.M., Rosen V., Wang E.A., and Wozney J.M. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci, USA 87 (1990) 9843-9847
31. Centrella M., Massague J., and Canalis E. Human platelet-derived transforming growth factor-β stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 119 (1986) 2306-2312
32. Centrella M., McCarthy T.L., and Canalis E. Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J. Biol Chem. 262 (1987) 2869-2874
33. Centrella M., McCarthy T.L., and Canalis E. Parathyroid hormone modulates transforming growth factor β activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. Proc. Natl. Acad. Sci. USA 85 (1988) 5889-5893
34. Centrella M., McCarthy T.L., and Canalis E. b2-microglobulin enhances insulin-like growth factor I receptor levels and synthesis in bone cell cultures. J. Biol. Chem. 264 (1989) 18268-18271
35. Centrella M., McCarthy T.L., and Canalis E. Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone. Mol. Cell. Biol. 11 (1991) 250-258
36. Centrella M., McCarthy T.L., and Canalis E. Glucocorticoid regulation of transforming growth factor β1 (TGFβ1) activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol. Cell. Biol. 11 (1991) 4490-4496
37. Centrella M., McCarthy T.L., and Canalis E. Transforming growth factor-beta and remodeling of bone. J. Bone Joint Surg. 73-A (1991) 1418-1428
38. Centrella M., McCarthy T.L., Kusmik W.F., and Canalis E. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factors in osteoblast-enriched cultures from fetal rat bone. J. Cell. Physiol. 147 (1991) 420-426
39. Centrella M., McCarthy T.L., Kusmik W.F., and Canalis E. Isoform specific regulation of platelet-derived growth factor activity and binding in osteoblast-enriched cultures from fetal rat bone. J. Clin. Invest. 89 (1992) 1076-1084
40. 1. J. Bone Miner. Res. 6 (1991) 1387-1393
41. 3 modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cell cultures. Endocrinology 128 (1991) 73-80
42. Chen D., Feng J.Q., Feng M., Harris M.A., Mundy G.R., and Harris S.E. Cloning and sequence of bone morphogenetic protein 4 cDNA from fetal rat calvarial cell. Biochim. Biophys. Acta 1174 (1993) 289-292
43. Chen R.-H., Ebner R., and Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260 (1993) 1335-1338
44. Chen T.L., Chang L.Y., DiGregorio D.A., Perlman A.J., and Huang Y.F. Growth factor modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cells. Endocrinology 133 (1993) 1382-1389
45. Chenu C., Pfeilschifter J., Mundy G.R., and Roodman G.D. Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc. Natl. Acad. Sci. USA 85 (1988) 5683-5687
46. Cheung P.-T., Wu J., Banach W., and Chernausek S.D. Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line. Endocrinology 135 (1994) 1328-1335
47. Chuang L.-M., Myers Jr. M.G., Seidner G.A., Birnbaum M.J., White M.F., and Kahn C.R. Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes. Proc. Natl. Acad. Sci. 90 (1993) 5172-5175
48. Claesson-Welsh L., Eriksson A., Westermark B., and Heldin C.-H. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc. Natl. Acad. Sci. USA 86 (1989) 4917-4921
49. Clemmons D.R., and Van Wyk J.J. Factors controlling blood concentrations of somatomedin C. Clin. Endocrinol. Metab. 13 (1984) 113-143
50. Cohick W.S., and Clemmons D.R. The insulin-like growth factors. Annu. Rev. Physiol. 55 (1993) 131-153
51. Conover C.A., and Kiefer M.C. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J. Clin. Endocrinol. Metab. 76 (1993) 1153-1159
52. Conover C.A., Bale L.K., Clarkson J.T., and Torring O. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. Endocrinology 132 (1993) 2525-2530
53. Conover C.A., Clarkson J.T., and Bale L.K. Phorbol ester tumor promoters regulate insulin-like growth factor-binding protein-4 proteolysis. Endocrinology 133 (1993) 1347-1351
54. Cuevas P., Burgos J., and Barid A. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem. Biophys. Res. Commun. 156 (1988) 611-618
55. Daughaday W.H., and Rotwein P. Insulin-like growth factor I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10 (1989) 68-91
56. Delany A.M., and Canalis E. Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. Endocrinology 136 (1995) 4776-4781
57. Delany A.M., Gabbitas B.Y., and Canalis E. Cortisol down-regulates osteoblast α1(I) procollagen mRNA by transcriptional and post-transcriptional mechanisms. J. Cell. Biochem. 57 (1995) 488-494
58. Derynck R., Jarrett J.A., Chen E.Y., and Goeddel D.V. The murine transforming growth factor-β precursor. J. Biol. Chem. 261 (1986) 4377-4379
59. Doctor J.S., Jackson P.D., Rashka K.E., Visalli M., and Hoffmann F.M. Sequence, biochemical characterization, and developmental expression of a new member of the TGF-β superfamily in Drosophila melanogaster. Dev. Biol. 151 (1992) 491-505
60. Ebeling P.R., Jones J.D., O'Fallon W.M., Janes C.H., and Riggs B.L. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J. Clin. Endocrinol. Metab. 77 (1993) 1384-1387
61. Ebner R., Chen R.-H., Shum L., Lawler S., Zioncheck T.F., Lee A., Lopez A.R., and Derynck R. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260 (1993) 1344-1348
62. Elenius K., Maatta A., Salmivirta M., and Jalkanen M. Growth factors induce 3T3 cells to express bFGF-binding syndecan. J. Biol. Chem. 267 (1992) 6435-6441
63. Eriksson A., Nister M., Leveen P., Westermark B., Heldin C.-H., and Claesson-Welsh L. Induction of platelet-derived growth factor α and β receptor mRNA and protein by platelet-derived growth factor BB. J. Biol. Chem. 266 (1991) 21138-21144
64. Ernst M., Heath J.K., and Rodan G.A. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125 (1989) 825-833
65. Esch F., Baird A., Ling N., Ueno N., Hill F., Denoroy L., Klepper R., Gospodarowicz D., Bohlen P., and Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc. Natl. Acad. Sci. USA 82 (1985) 6507-6511
66. 28]insulin-like growth factor-I-stimulated proliferation and collagen synthesis in fetal rat calvariae. J. Biol. Chem. 266 (1991) 19469-19474
67. Finkelman R.D., Bell N.H., Strong D.D., Demers L.M., and Baylink D.J. Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: Implications for estrogen deficiency-associated bone loss. Proc. Natl. Acad. Sci. USA 89 (1992) 12190-12193
68. Finkelstein J.S., Klibanski A., Schaefer E.H., Hornstein M.D., Schiff I., and Neer R.M. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N. Engl. J. Med. 331 (1994) 1618-1623
69. Fowlkes J.L., Suzuki K., Nagase H., and Thrailkill K.M. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: A role for matrix metalloproteinases. Endocrinology 135 (1994) 2810-2813
70. Gabbitas B., Pash J., and Canalis E. Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors. Endocrinology 135 (1994) 284-289
71. Gilardetti R.S., Chaibi M.S., Stroumza J., Williams S.R., Antoniades H.N., Carnes D.C., and Graves D.T. High-affinity binding of PDGF-AA and PDGF-BB to normal human osteoblastic cells and modulation by interluekin-1. Am. J. Physiol. 261 (1991) C980-C985
72. Giorgetti S., Pelicci P.G., Pelicci G., and Van Obberghen E. Involvement of Srchomology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Eur. J. Biochem. 223 (1994) 195-202
73. Globus R.K., Plouet J., and Gospodarowicz D. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124 (1989) 1539-1547
74. Goldsmith K.T., Gammon R.B., and Garver Jr. R.I. Modulation of bFGF in lung fibroblasts by TGF-β and PDGF. Am. J. Physiol. 261 (1991) L378-L385
75. Graves D.T., Owen A.J., Barth R.K., Tempst P., Winoto A., Fors L., Hood L.E., and Antoniades H.N. Detection of c-sis transcripts and synthesis of PDGF-like proteins by human osteosarcoma cells. Science 226 (1984) 972-974
76. Gronwald R.G.K., Grant F.J., Haldeman B.A., Hart C.E., O'Hara P.J., Hagen F.S., Ross R., Bowen-Pope D.F., and Murray M.J. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. Proc. Natl. Acad. Sci. USA 85 (1988) 3435-3439
77. Gronwald R.G.K., Seifert R.A., and Bowen-Pope D.R. Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-β. J. Biol. Chem. 264 (1989) 8120-8125
78. 2α stimulates proliferation of clonal osteoblastic MC3T3-E1 cells by up-regulation of insulin-like growth factor I receptors. J. Biol. Chem. 266 (1991) 21044-21050
79. Hall L.J., Kajimoto Y., Bichell D., Kim S.-W., James P.L., Counts D., Nixon L.J., Tobin G., and Rotwein P. Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol. 11 (1992) 301-313
80. Hassager C., Fitzpatrick L.A., Spencer E.M., Riggs B.L., and Conover C.A. Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. J. Clin. Endocrinol. Metab. 75 (1992) 228-233
81. Heldin C.-H., and Westermark B. PDGF-like growth factors in autocrine stimulation of growth. J. Cell. Physiol. Suppl. 5 (1987) 31-34
82. Heldin C.-H., and Westermark B. Platelet-derived growth factors: A family of isoforms that bind to two distinct receptors. Br. Med. Bull. 45 (1989) 453-464
83. Heldin C.-H., Johnsson A., Wennergren S., Wersnstedt C., Betsholtz C., and Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319 (1986) 511-514
84. 15509-1552. Hepler J.E., Van Wyk J.J., and Lund P.K. Different half-lives of insulin-like growth factor I mRNAs that differ in length of 3′ untranslated sequence. Endocrinology 127 (1990)
85. Hober S., Hansson A., Uhlen M., and Nilsson B. Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein. Biochemistry 33 (1994) 6758-6761
86. Hock J.M., and Canalis E. Platelet-derived growth factor enhances bone cell replication but not differentiated function of osteoblasts. Endocrinology 134 (1994) 1423-1428
87. Hock J., Centrella M., and Canalis E. Insulin-like growth factor I (IGF-I) has independent effects on bone matrix formation and cell replication. Endocrinology 122 (1988) 254-260
88. Hock J., Canalis E., and Centrella M. Transforming growth factor beta (TGF-beta-1) stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126 (1990) 421-426
89. Hoyt E.C., Hepler J.E., VanWyk J.J., and Lund P.K. Structural characterization of exon 6 of the rat IGF-I gene. DNA Cell Biol. 11 (1992) 433-441
90. Hurley M.M., Abreu C., Harrison J.R., Lichtler A.C., Raisz L.G., and Kream B.E. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268 (1993) 5588-5593
91. Hurley M.M., Abreu C., Gronowicz G., Kawaguchi H., and Lorenzo J. Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J. Biol. Chem. 269 (1994) 9392-9396
92. Ignotz R.A., and Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261 (1986) 4337-4345
93. Jabs E.W., Li X., Scott A.F., Meyers G., Chen W., Eccles M., Mao J.-i., Charnas L.R., Jackson C.E., and Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature 8 (1994) 275-279
94. Jackson A., Friedman S., Zhan X., Engleka K.A., Forough R., and Maciag T. Heat shock induces the release of fibroblast growth factor I from NIH 3T3 cells. Proc. Natl. Acad. Sci, USA 89 (1992) 10691-10695
95. Jones C.M., Simon-Chazottes D., Guenet J.-L., and Hogan B.L.M. Isolation of Vgr-2, a novel member of the transforming growth factor-β-related gene family. Mol. Endocrinol. 6 (1992) 1961-1968
96. Jones J.I., Gockerman A., Busby Jr. W.H., Camacho-Hubner C., and Clemmons D.R. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J. Cell Biol. 121 (1993) 679-687
97. Joyce M.L., Roberts A.B., Sporn M.B., and Bolander M.E. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110 (1990) 2195-2207
98. Kachra Z., Yang C.-R., and Posner B.I. The augmentation of insulin-like growth factor-I messenger ribonucleic acid in cultured rat hepatocytes: Activation of protein kinase-A and -C is necessary, but not sufficient. Endocrinology 134 (1994) 702-708
99. Kanzaki S., Hilliker S., Baylink D.J., and Mohan S. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 134 (1994) 383-392
100. Kavanaugh W.M., Harsh I., G.R., Starksen N.S., Rocco C.M., and Williams L.T. Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells. J. Biol. Chem. 263 (1988) 8470-8472
101. Kawaguchi H., Kurokawa T., Hanada K., Hiyama Y., Tamura M., Ogata E., and Matsumoto T. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135 (1994) 774-781
102. Kim S.-J., Glick A., Sporn M.B., and Roberts A.B. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol. Chem. 264 (1989) 402-408
103. Kim S.-J., Jeang K.T., Glick A.B., Sporn M.B., and Roberts A.B. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction. J. Biol. Chem. 264 (1989) 7041-7045
104. Kingsley D.M. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8 (1994) 133-146
105. Klagsbrun M., and Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 67 (1991) 229-231
106. Knutsen R., Wergedal J.E., Sampath T.K., Baylink D.J., and Mohan S. Osteogenic protein-1 stimulates proliferation and differentiation of human bone cell in vitro. Biochem. Biophys. Res. Commun. 194 (1993) 1352-1358
107. 3. Endocrinology 126 (1990) 2088-2094
108. Lafyatis R., Lechleider R., Kim S.-J., Jakowlew S., Roberts A.B., and Sporn M.B. Structural and functional characterization of the transforming growth factor β3 promoter. J. Biol. Chem. 265 (1991) 19128-19136
109. Laiho M., Weis F.M.B., and Massague J. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGFβ-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265 (1990) 18518-18524
110. Lane T.L., and Sage E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8 (1994) 163-173
111. LaTour D., Mohan S., Linkhart T.A., Baylink D.J., and Strong D.D. Inhibitory insulin-like growth factor-binding protein: Cloning, complete sequence, and physiological regulation. Mol. Endocrinol. 4 (1990) 1806-1814
112. Lin H.Y., Wang X.-F., Ng-Eaton E., Weinberg R., and Lodish H. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68 (1992) 775-785
113. Lin X., Wang Z., Gu L., and Deuel T.F. Functional analysis of the human platelet-derived growth factor A-chain promoter region. J. Biol. Chem. 267 (1992) 25614-25619
114. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75 (1993) 59-72
115. Lopez-Casillas F., Payne H.M., Andres J.L., and Massague J. Betaglycan can act as a dual modulator of TGFβ access to signaling receptors: Mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124 (1994) 557-568
116. Lund P.K., Hoyt E.C., and Van Wyk J.J. The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of the 3′ end. Mol. Endocrinol. 3 (1989) 2054-2061
117. Luyten F.P., Cunningham N.S., Ma S., Muthukumaran N., Hammonds R.G., Nevins W.B., Wood W.I., and Reddi A.H. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J. Biol. Chem. 264 (1989) 13377-13380
118. Lynch S.E., Nixon J.C., Colvin R.B., and Antoniades H.N. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc. Natl. Acad. Sci. USA 84 (1987) 7696-7700
119. Lyons K.M., Jones C.M., and Hogan B.L. The DVR gene family in embryonic development. Trends Genet. 7 (1991) 408-412
120. Mali M., Elenius K., Miettinen H.M., and Jalkanen M. Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J. Biol. Chem. 268 (1993) 24215-24222
121. Marcelli C., Yates A.J., and Mundy G.R. In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice. J. Bone Miner. Res. 5 (1990) 1087-1096
122. Martin T.J., and Ng K.W. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J. Cell. Biochem. 56 (1994) 357-366
123. Matrisian L.M., and Hogan B.L.M. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Top. Dev. Biol. 24 (1990) 219-259
124. McCarthy T.L., Centrella M., and Canalis E. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 125 (1989) 2118-2126
125. McCarthy T.L., Centrella M., and Canalis E. Regulatory effects of insulin-like growth factor I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124 (1989) 301-309
126. McCarthy T.L., Casinghino S., Centrella M., and Canalis E. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: Regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. J. Cell. Physiol. 160 (1994) 163-175
127. Migdalska A., Molineux G., Demuynck H., Evans G.S., Ruscetti F., and Dexter T.M. Growth inhibitory effects of transforming growth factor-β1 in vivo. Growth Factors 4 (1991) 239-245
128. Mohan S., Bautista C.M., Wergedal J., and Baylink D.J. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc. Natl. Acad. Sci. USA 86 (1989) 8338-8342
129. Montesano R., Vassalli J.D., Baird A., Guillemin R., and Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 83 (1986) 7297-7301
130. 3 stimulates the secretion of insulin-like growth factor binding protein 3 (IGFBP-3) by cultured human osteosarcoma cells. Endocrinology 130 (1992) 1071-1073
131. Mueller K., Cortesi R., Modrowski D., and Marie P.J. Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomized rats. Endocrinol. Metab. 30 (1994) E1-E6
132. Muenke M., Schell U., Hehr A., Robin N.H., Losken H.W., Schinzel A., Pulleryn L.J., Rutland P., Reardon W., Malcolm S., and Winter R.M. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genetics 8 (1994) 269-274
133. Murray S.S., Murray E.J.B., Glackin C.A., and Urist M.R. Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells. J. Cell. Biochem. 53 (1993) 51-60
134. Nakayama H., Ichikawa F., Andres J.L., Massague J., and Noda M. Dexamethasone enhancement of betaglycan (TGF-β type III receptor) gene expression in osteoblast-like cells. Exp. Cell Res. 211 (1994) 301-306
135. Nam T.J., Busby Jr. W.H., and Clemmons D.R. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology 135 (1994) 1385-1391
136. Nellen D., Affolter M., and Basler K. Receptor serine/threonine kinases implicated in the control of drosophila body pattern by decapentaplegic. Cell 78 (1994) 225-237
137. Nicolas V., Prewett A., Bettica P., Mohan S., Finkelman R.D., Baylink D.J., and Farley J.R. Age-related decreases of insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: Implications for bone loss with aging. J. Clin. Endocrinol. Metab. 78 (1994) 1011-1016
138. Noda M. Transcriptional regulation of osteocalcin production by transforming growth factor-β in rat osteoblast-like cells. Endocrinology 124 (1989) 612-617
139. Noda M., and Rodan G.A. Type β transforming growth factor (TGF β) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J. Cell. Physiol. 133 (1987) 426-437
140. Noda M., and Vogel R. Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells. J. Cell Biol. 109 (1989) 2529-2535
141. Noda M., Yoon K., Prince C.W., Butler W.T., and Rodan G.A. Transcriptional regulation of osteopontin productionin rat osteosarcoma cells by type β transforming growth factor. J. Biol. Chem. 263 (1988) 13916-13921
142. Noma T., Glick A.B., Geiser A.G., O'Reilly M.A., Miller J., Roberts A.B., and Sporn M.B. Molecular cloning and structure of the human transforming growth factor-β2 gene promoter. Growth Factors 4 (1991) 247-255
143. Ogawa Y., Schmidt D.K., Dasch J.R., Chang R.-J., and Glaser C.B. Purification and characterization of transforming growth factor-β2.3 and -β1.2 heterodimers from bovine bone. J. Biol. Chem. 267 (1992) 2325-2328
144. Ogata T., Wozney J.M., Benezra R., and Noda M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc. Natl. Acad. Sci. USA 90 (1993) 9219-9222
145. Oh Y., Muller H.L., Lamson G., and Rosenfeld R.G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J. Biol. Chem. 268 (1993) 14964-14971
146. Okazaki R., Riggs B.L., and Conover C.A. Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology 134 (1994) 126-132
147. Oursler M.J., Cortese C., Keeting P., Anderson M.A., Bonde S.K., Riggs B.L., and Spelsberg T.C. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129 (1991) 3313-3320
148. Oursler M.J., Riggs B.L., and Spelsberg T.C. Glucocorticoid-induced activation of latent transforming growth factor-β by normal human osteoblast-like cells. Endocrinology 133 (1993) 2187-2196
149. Owen T.A., Bortell R., Shalhoub V., Heinrichs A., Stein J.L., Stein G.S., and Lian J.B. Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. Proc. Natl. Acad. Sci. USA 90 (1993) 1503-1507
150. Ozkaynak E., Rueger D.C., Drier E.A., Corbett C., Ridge R.J., Sampath T.K., and Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J. 9 (1990) 2085-2093
151. Ozkaynak E., Schnegelsberg P.N.J., Jin D.F., Clifford G.M., Warren F.D., Drier E.A., and Oppermann H. Osteogenic protein-2. A new member of the transforming growth factor-β superfamily expressed early in embryogenesis. J. Biol. Chem. 267 (1992) 25220-25227
152. 2 in osteoblast cells. Endocrinology (1995)
153. Pech M., Rao C.D., Robbins K., and Aaronson S.A. Functional identification of regulatory elements within the promoter region of platelet-derived growth factor 2. Mol. Cell. Biol. 9 (1989) 396-405
154. Pelton R.W., Dickinson M.E., Moses H.L., and Hogan B.L.M. In situ hybridization analysis of TGFβ3 RNA expression during mouse development: Comparative studies with TGF β1 and β2. Development 110 (1990) 609-620
155. Penton A., Chen Y., Staehling-Hampton K., Wrana J.L., Attisano L., Szidonya J., Cassill J.A., Massague J., and Hoffmann F.M. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell 78 (1994) 239-250
156. Pfeilschifter J., Seyedin S.M., and Mundy G.R. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. J. Clin. Invest. 82 (1988) 680-685
157. Pierce G.F., Mustoe T.A., Altrock B.W., Deuel T.F., and Thomason A. Role of platelet-derived growth factor in wound healing. J. Cell. Biochem. 45 (1991) 319-326
158. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., and Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad, Sci. USA 89 (1992) 1281-1285
159. Reardon W., Winter R.M., Rutland P., Pulleryn L.J., Jones B.M., and Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genetics 8 (1994) 98-103
160. Rechler M.M. Insulin-like growth factor binding proteins. Vitam. Horm. 47 (1993) 1-117
161. Reddi A.H. Regulation of local differentiation of cartilage and bone by extracellular matrix: C cascade type mechanism. Prog. Clin. Biol. Res. (1983) 261-268
162. Reddi A.H., and Cunningham N.S. Recent progress in bone induction by osteogenin and bone morphogenetic proteins: Challenges for biomechanical and tissue engineering. J. Biomech. Eng. 113 (1991) 189-190
163. Rodan G.A., and Martin T.J. Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calcif. Tissue Int. 33 (1981) 349-351
164. Rodan S.B., Wesolowski G., Yoon K., and Rodan G.A. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 264 (1989) 19934-19941
165. Rorsman F., Bywater M., Knott T.J., Scott J., and Betsholtz E. Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: Alternative exon usage predicts two different precursor proteins. Mol. Cell. Biol. 8 (1988) 571-577
166. Rosen D.M., Stempien S.A., Thompson A.Y., and Seyedin S.M. Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro. J. Cell. Physiol. 134 (1988) 337-346
167. Rosen D., Miller SC., DeLeon E., Thompson A.Y., Bentz H., Mathews M., and Adams S. Systemic administration of recombinant transforming growth factor beta 2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15 (1994) 355-359
168. Rousseau F., Bonaventure J., Legeal-Mallet L., Pelet A., Rozet J.-M., Maroteaux P., LeMerrer M., and Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371 (1994) 252-254
169. Rubini M., Werner H., Gandini E., Roberts Jr. C.T., LeRoith D., and Baserga R. Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene. Exp. Cell Res. 211 (1994) 374-379
170. In press. Rydziel S., and Canalis E. Expression and growth factor regulation of platelet-derived growth factor B transcripts in primary osteoblast cell cultures. Endocrinology 137 (1996)
171. Rydziel S., Ladd C., McCarthy T.L., Centrella M., and Canalis E. Determination and expression of platelet-derived growth factor-AA in bone cell cultures. Endocrinology 130 (1992) 1916-1922
172. Rydziel S., Shaikh S., and Canalis E. Platelet-derived growth factors AA and BB enhance the synthesis of platelet-derived growth factor AA in bone cell cultures. Endocrinology 134 (1994) 2541-2546
173. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., White K.H., Coughlin J.E., Tucker M.M., Pang R.H.L., Corbett C., Ozkaynak E., Opperman H., and Rueger D.C. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267 (1992) 20352-20362
174. Sampath T.K., Rashka K.E., Doctor J.S., Tucker R.F., and Hoffman F.M. Drosophila transforming growth factor β superfamily proteins induce endochondral bone formation in mammals. Proc. Natl. Acad. Sci. USA 90 (1993) 6004-6008
175. 3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129 (1991) 3139-3146
176. Schollman C., Grugel R., Tatje D., Hoppe J., Folkman J., Marme D., and Weich H.A. Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific up-regulation of the PDGF α receptor in vascular smooth muscle cells. J. Biol. Chem. 267 (1992) 18032-18039
177. Seifert R.A., Hart C.E., Phillips P.E., Forstrom J.W., Ross R., Murray M.J., and Bowen-Pope D.W. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264 (1989) 8771-8778
178. Shiang R., Thompson L.M., Zhu Y.-Z., Church D.M., Fielder T.J., Bocian M., Winokur S.R., and Wasmuth J.J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 (1994) 335-342
179. Shibata F., Baird A., and Florkiewicz R.Z. Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors 4 (1991) 277-287
180. Shibata Y., Abiko Y., Moriya Y., Yoshida W., and Takiguchi H. Effects of transforming growth factor-β on collagen gene expression and collagen synthesis level in mineralizing cultures of osteoblast-like cell line, MC3T3-E1. Int. J. Biochem. 25 (1993) 239-245
181. Shinar D.M., and Rodan G.A. Biphasic effects of transforming growth factor-β on the production of osteoclast-like cells in mouse bone marrow cultures: The role of prostaglandins in the generation of these cells. Endocrinology 126 (1990) 3153-3158
182. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., and Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
183. Takuwa Y., Ohse C., Wang E.A., Wozney J.M., and Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem. Biophys. Res. Commun. 174 (1991) 96-101
184. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C.-H., and Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269 (1994) 16985-16988
185. Thies R.S., Bauduy M., Ashton B.A., Kurtzberg L., Wozney J.M., and Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130 (1992) 1318-1324
186. Tsukamoto T., Matsui T., Nakata H., Ito M., Natazuka T., Fukase M., and Fujita T. Interleukin-1 Enhances the response of osteoblasts to platelet-derived growth factor through the a receptor-specific up-regulation. J. Biol. Chem. 16 (1991) 10143-10147
187. Umayahara Y., Kawamori R., Watada H., Imano E., Iwama N., Morishima T., Yamasaki Y., Kajimoto Y., and Kamada T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269 (1994) 16433-16442
188. van Dijk M.A., van Schaik F.M.A., Bootsma H.J., Holthuizen P., and Sussenbach J.S. Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol. Cell. Endocrinol. 81 (1991) 81-94
189. Vukicevic S., Luyten F.P., and Reddi A.H. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc. Natl. Acad. Sci. USA 86 (1989) 8793-8797
190. Vuori K., and Ruoslahti E. Association of insulin receptor substrate-1 with integrins. Science 266 (1994) 1576-1578
191. Wakefield L.M., Smith D.M., Flanders K.C., and Sporn M.B. Latent transforming growth factor-β from human platelets. J. Biol. Chem. 263 (1988) 7646-7654
192. Wall N.A., Blessing M., Wright C.V.E., and Hogan B.L.M. Biosynthesis and in vivo localization of the decapentaplegic-vg-related protein, DVR-6 (bone morphogenetic protein-6). J. Cell. Biol. 120 (1993) 493-502
193. Wang J., Gao G., and Goldfarb M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol. 14 (1994) 181-188
194. Wang X.-F., Lin H.Y., Ng-Eaton E., Downward J., Lodish H.F., and Weinberg R.A. Expression cloning and characterization of the TGF-β type III receptor. Cell 67 (1991) 797-805
195. Way B.A., and Mooney R.A. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase. J. Biol. Chem. 268 (1993) 26409-26415
196. Westermark B., and Heldin C.-H. Platelet-derived growth factor. Acta Oncol. 32 (1993) 101-105
197. Wharton K.A., Thomsen G.H., and Gelbart W.M. Drosophila 60A gene, another transforming growth factor beta family member, is closely related to human bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA 88 (1991) 9214-9218
198. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., and Wang E.A. Novel regulators of bone formation: Molecular clones and activities. Science 242 (1988) 1528-1534
199. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., Kahn A.J., Suda T., and Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113 (1991) 681-687
200. Yarden Y., Escobedo J.A., Kuang W.-J., Yang-Feng T.L., Daniel T.O., Tremble P.M., Chen E.Y., Ando M.E., Harkins R.N., Francke U., Fried V.A., Ullrich A., and Williams L.T. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323 (1986) 226-232
201. Zheng M.H., Wood D.J., Wysocki S., Papadimitriou J.M., and Wang E.A. Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-β1 genes in normal human osteoblast-like cells. J. Cell. Physiol. 159 (1994) 76-82